Mi Li
6PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 22, 2026
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction.Linjie Luo, Yan Wang, Tuyen Bui
|Aug 26, 2024
Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer.Mi Li, Amriti R Lulla, Yan Wang
|Jan 03, 2024
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance.Hyemin Lee, Amber Horbath, Lavanya Kondiparthi
|Jan 05, 2023
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.Tuyen Duong Thanh Nguyen, Yan Wang, Tuyen N Bui
|Nov 07, 2022
Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer.Mi Li, Spiridon Tsavachidis, Fuchenchu Wang
|May 13, 2022
Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.Xu Feng, Mengfan Tang, Merve Dede
Pageof 1
Frequent Collaborators
5 joint publications
Khandan Keyomarsi
4 joint publications
Kelly K Hunt
3 joint publications
Yan Wang
2 joint publications
Mei-Kuang Chen
2 joint publications
Marc A Pina
2 joint publications
Tuyen N Bui
2 joint publications
Nicole M Kettner
2 joint publications
Tuyen Duong Thanh Nguyen
2 joint publications
Cansu Karakas
2 joint publications
Linjie Luo
